Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 121

1.

Redesigning a large-scale clinical trial in response to negative external trial results: the CAMUS study of phytotherapy for benign prostatic hyperplasia.

Lee J, Andriole G, Avins A, Crawford ED, Foster H, Kaplan S, Kreder K, Kusek J, McCullough A, McVary K, Meleth S, Naslund M, Nickel JC, Nyberg L, Roehrborn C, Dale Williams O, Barry M.

Clin Trials. 2009 Dec;6(6):628-36. doi: 10.1177/1740774509352199. Epub 2009 Dec 9.

PMID:
20007408
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Phytotherapy for benign prostatic hyperplasia.

Wilt TJ, Ishani A, Rutks I, MacDonald R.

Public Health Nutr. 2000 Dec;3(4A):459-72.

PMID:
11276294
[PubMed - indexed for MEDLINE]
3.

Serenoa repens for benign prostatic hyperplasia.

Tacklind J, Macdonald R, Rutks I, Stanke JU, Wilt TJ.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD001423. doi: 10.1002/14651858.CD001423.pub3. Review.

PMID:
23235581
[PubMed - indexed for MEDLINE]
4.

Pygeum africanum for benign prostatic hyperplasia.

Wilt T, Ishani A, Mac Donald R, Rutks I, Stark G.

Cochrane Database Syst Rev. 2002;(1):CD001044. Review.

PMID:
11869585
[PubMed - indexed for MEDLINE]
5.

Serenoa repens for benign prostatic hyperplasia.

Tacklind J, MacDonald R, Rutks I, Wilt TJ.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD001423. doi: 10.1002/14651858.CD001423.pub2. Review. Update in: Cochrane Database Syst Rev. 2012;12:CD001423.

PMID:
19370565
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic review.

MacDonald R, Tacklind JW, Rutks I, Wilt TJ.

BJU Int. 2012 Jun;109(12):1756-61. doi: 10.1111/j.1464-410X.2012.11172.x. Epub 2012 May 2. Review.

PMID:
22551330
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Serenoa repens for benign prostatic hyperplasia.

Wilt T, Ishani A, Mac Donald R.

Cochrane Database Syst Rev. 2002;(3):CD001423. Review. Update in: Cochrane Database Syst Rev. 2009;(2):CD001423.

PMID:
12137626
[PubMed - indexed for MEDLINE]
8.

Recruitment of participants to a clinical trial of botanical therapy for benign prostatic hyperplasia.

Lee JY, Foster HE Jr, McVary KT, Meleth S, Stavris K, Downey J, Kusek JW.

J Altern Complement Med. 2011 May;17(5):469-72. doi: 10.1089/acm.2010.0300. Epub 2011 May 9.

PMID:
21554128
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Observational database serenoa repens (DOSSER): overview, analysis and results. A multicentric SIUrO (Italian Society of Oncological Urology) project.

Bertaccini A, Giampaoli M, Cividini R, Gattoni GL, Sanseverino R, Realfonso T, Napodano G, Fandella A, Guidoni E, Prezioso D, Galasso R, Cicalese C, Scattoni V, Armenio A, Conti G, Corinti M, Spasciani R, Liguori G, Lampropoulou N, Martorana G.

Arch Ital Urol Androl. 2012 Sep;84(3):117-22.

PMID:
23210402
[PubMed - indexed for MEDLINE]
10.

Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review.

Wilt TJ, Ishani A, Stark G, MacDonald R, Lau J, Mulrow C.

JAMA. 1998 Nov 11;280(18):1604-9. Erratum in: JAMA 1999 Feb 10;281(6):515.

PMID:
9820264
[PubMed - indexed for MEDLINE]
11.

A phase II randomised double-blind placebo-controlled clinical trial investigating the efficacy and safety of ProstateEZE Max: a herbal medicine preparation for the management of symptoms of benign prostatic hypertrophy.

Coulson S, Rao A, Beck SL, Steels E, Gramotnev H, Vitetta L.

Complement Ther Med. 2013 Jun;21(3):172-9. doi: 10.1016/j.ctim.2013.01.007. Epub 2013 Feb 23.

PMID:
23642948
[PubMed - indexed for MEDLINE]
12.

Phytotherapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia.

Dedhia RC, McVary KT.

J Urol. 2008 Jun;179(6):2119-25. doi: 10.1016/j.juro.2008.01.094. Epub 2008 Apr 18. Review.

PMID:
18423748
[PubMed - indexed for MEDLINE]
13.

Is there a scientific basis for the therapeutic effects of serenoa repens in benign prostatic hyperplasia? Mechanisms of action.

Buck AC.

J Urol. 2004 Nov;172(5 Pt 1):1792-9. Review.

PMID:
15540722
[PubMed - indexed for MEDLINE]
14.

Serenoa repens (Permixon). A review of its pharmacology and therapeutic efficacy in benign prostatic hyperplasia.

Plosker GL, Brogden RN.

Drugs Aging. 1996 Nov;9(5):379-95. Review.

PMID:
8922564
[PubMed - indexed for MEDLINE]
15.

Updated meta-analysis of clinical trials of Serenoa repens extract in the treatment of symptomatic benign prostatic hyperplasia.

Boyle P, Robertson C, Lowe F, Roehrborn C.

BJU Int. 2004 Apr;93(6):751-6.

PMID:
15049985
[PubMed - indexed for MEDLINE]
16.

Serenoa repens extract for benign prostate hyperplasia: a randomized controlled trial.

Willetts KE, Clements MS, Champion S, Ehsman S, Eden JA.

BJU Int. 2003 Aug;92(3):267-70.

PMID:
12887481
[PubMed - indexed for MEDLINE]
17.

Phytotherapy for benign prostatic hyperplasia.

Gerber GS.

Curr Urol Rep. 2002 Aug;3(4):285-91. Review.

PMID:
12149159
[PubMed - indexed for MEDLINE]
18.

A scientific basis for the therapeutic effects of Pygeum africanum and Serenoa repens.

Levin RM, Das AK.

Urol Res. 2000 Jun;28(3):201-9. Review.

PMID:
10929430
[PubMed - indexed for MEDLINE]
19.

Monotherapy versus combination drug therapy for the treatment of benign prostatic hyperplasia.

Logan YT, Belgeri MT.

Am J Geriatr Pharmacother. 2005 Jun;3(2):103-14. Review.

PMID:
16129387
[PubMed - indexed for MEDLINE]
20.

The role of phytotherapy in treating lower urinary tract symptoms and benign prostatic hyperplasia.

Dreikorn K.

World J Urol. 2002 Apr;19(6):426-35. Review.

PMID:
12022711
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk